Skip to content

Neumora Therapeutics, Inc.

NMRA · XNAS

CIK 1885522fmd_1H02YV34X97HKQCQP7G97N5VFVManufacturing · Biological Products, (No Diagnostic Substances)Template: Standard

Coverage: Jan 01, 2022 to Jun 30, 2026, 18 periods

News summary

An AI model writes the summary on request, from this company's recent filings only, and cites each filing it uses.

AI-written
0 filings

From 8-K filings, not wire news: the items each filer selected on the EDGAR cover, grouped by event type. Importance is FinancialMD's own rule by item number (5: bankruptcy, non-reliance, change of control, delisting, cybersecurity; 1: exhibits only).

Loading